Rare case of catastrophic antiphospholipid syndrome with spontaneous intracranial haemorrhage.
Anju AdhikariMohammad Muhsin ChistiSanjog BastolaOjbindra KcPublished in: BMJ case reports (2019)
Catastrophic antiphospholipid syndrome (CAPS) is a rare but severe form of antiphospholipid syndrome (APS). The syndrome manifests itself as a rapidly progressive multiorgan failure that is believed to be caused by widespread micro-thrombosis. Seldom does bleeding comanifest with thrombosis. We present a patient with APS who presented with nausea, vomiting and fatigue, and rapidly progressed into multiorgan failure before being diagnosed with CAPS. The clinical course was complicated by an atraumatic intracranial haemorrhage which demanded discontinuation of anticoagulation. The patient was treated with high dose steroid, intravenous immunoglobulin, followed by weekly rituximab infusion. Although the trigger for CAPS was not obvious during her hospital stay, she was diagnosed with acute cytomegalovirus (CMV) infection soon after discharge. In this case report, we explore the differential diagnoses of CAPS, investigate the possibility of CMV infection as a potential trigger, present the therapeutic challenges of anticoagulation and discuss the emerging use of rituximab.
Keyphrases
- case report
- high dose
- rare case
- atrial fibrillation
- diffuse large b cell lymphoma
- low dose
- pulmonary embolism
- venous thromboembolism
- liver failure
- multiple sclerosis
- chemotherapy induced
- hodgkin lymphoma
- healthcare
- stem cell transplantation
- chronic lymphocytic leukemia
- optic nerve
- drug induced
- early onset
- emergency department
- epstein barr virus
- respiratory failure
- intensive care unit
- sleep quality
- physical activity
- human health
- newly diagnosed